Proshare - Facebook Proshare - Twitter Proshare - Google+ Proshare - Linked In Proshare - RSS Feed

GlaxoSmithKline Consumer Nigeria Plc Appoints Mr. Bhushan Akshikar as a Non-Executive Director

Proshare

Monday, March 13, 2017/ 4:22 PM /NSE

Please be informed that at the meeting of the Board of Directors of GlaxoSmithKline Consumer Nigeria Plc held on 9th March 2017 at GSK House, I, Industrial Avenue, Ilupeju, Lagos, and the Board accepted the resignations of

1.       Mr. Jonathan Girling and Mr. Cesar Marval, formerly non-executive directors, with effect from 8th March 2017 respectively.

2.      Mr. Olaleye Peter Dada, formerly Assistant Company Secretary, with effect from March 8, 2017

The Board appointed Mr. Bhushan Akshikar as non-executive Director of the company effective 9th March 2017.

Mr. Akshikar is currently the general Manager of GlaxoSmithKline Pharmaceutical Nigeria Limited. He started his career with MSD, India in 1992 as a Medical Representative/District Manager.

In 2006, he joined Janssen Cilag, India as the Product Manager. Since then he has held several increasing management roles.

He served in various roles such as Group Product Manager, Gastroenterology, Marketing Manager, Oncology Franchise, Marketing Support Manager-Nephrology, Regional Sales Manager and Vice President, Sales, Marketing & Supply Chain within the same company.

In 2011, he joined GSK India as Executive Vice President leading the mass business (Primary care, Rural team and Dermatology) vertical and the respiratory business of GSK  India to deliver over £120m in annual sales revenue.

In January 2017, Mr. Bhushan was appointed General Manager, GlaxoSmithKline Pharmaceutical Nigeria Limited. Mr. Akshikar holds a Bachelor of Pharmacy from the University of Poona, India and an MBA from S.P Jain Institute of Management & Research, Mumbai, India.

The Board is confident that with his vast experience in Sales, Marketing and Supply chain, Mr. Akshikar would bring to his role as a non-executive director, the requisite skills and expertise currently required by the Board of GlaxoSmithKline Consumer Nigeria Plc.
 

READ MORE:
Related News